These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30931853)

  • 1. Valproic Acid and the Liver Injury in Patients with Epilepsy: An Update.
    Guo HL; Jing X; Sun JY; Hu YH; Xu ZJ; Ni MM; Chen F; Lu XP; Qiu JC; Wang T
    Curr Pharm Des; 2019; 25(3):343-351. PubMed ID: 30931853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Valproic Acid and Its Main Metabolites' Plasma Concentrations with Clinical Outcomes among Epilepsy Patients: A 10-Year Retrospective Study Based on Therapeutic Drug Monitoring.
    Li RT; Chen ZY; Tang SY; Wen DS; Ren RN; Zhang XX; Liu SZ; Zhou S; Wang XD; Zhou LM; Huang M
    Drug Metab Dispos; 2024 Feb; 52(3):210-217. PubMed ID: 38195521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of metformin and sub-therapeutic dose of valproic acid prevent valproic acid-induced toxicity in animal model of epilepsy.
    Jamal M; Azam M; Simjee SU
    Drug Chem Toxicol; 2024 May; 47(3):287-295. PubMed ID: 36650908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of naringin on valproic acid-induced hepatotoxicity in rats.
    Koroglu OF; Gunata M; Vardi N; Yildiz A; Ates B; Colak C; Tanriverdi LH; Parlakpinar H
    Tissue Cell; 2021 Oct; 72():101526. PubMed ID: 33756270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymerase γ gene POLG determines the risk of sodium valproate-induced liver toxicity.
    Stewart JD; Horvath R; Baruffini E; Ferrero I; Bulst S; Watkins PB; Fontana RJ; Day CP; Chinnery PF
    Hepatology; 2010 Nov; 52(5):1791-6. PubMed ID: 21038416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic Acid-Associated Hyperammonemia: A Systematic Review.
    Wong YJ; Fan J; Wan A; Mihic T; Gnyra M
    J Clin Psychopharmacol; 2023 May-Jun 01; 43(3):283-294. PubMed ID: 37126830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the glutamate-glutamine cycle on valproic acid-associated hepatotoxicity in pediatric patients with epilepsy.
    Ma L; Zhu J; Kong X; Chen L; Du J; Yang L; Wang D; Wang Z
    Clin Toxicol (Phila); 2024 Jun; 62(6):364-371. PubMed ID: 38913595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in the susceptibility to valproic acid-associated liver injury in epileptic patients.
    Ma L; Wang D
    Clin Toxicol (Phila); 2024 Feb; 62(2):101-106. PubMed ID: 38512019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid triggers increased mitochondrial biogenesis in POLG-deficient fibroblasts.
    Sitarz KS; Elliott HR; Karaman BS; Relton C; Chinnery PF; Horvath R
    Mol Genet Metab; 2014 May; 112(1):57-63. PubMed ID: 24725338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between one-carbon metabolism and valproic acid-induced liver dysfunction in epileptic patients.
    Zhu J; Wang Z; Sun X; Wang D; Xu X; Yang L; Du J; Zhou Z; Qi Y; Ma L
    Front Pharmacol; 2024; 15():1358262. PubMed ID: 38464726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologically based mechanistic insight into differential risk of valproate hepatotoxicity between children and adults: A focus on ontogeny impact.
    Huang YT; Huang YM; Kung FL; Lin CJ; Jao T; Ho YF
    CPT Pharmacometrics Syst Pharmacol; 2023 Dec; 12(12):1960-1971. PubMed ID: 37735924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium valproate and hepatotoxicity in epileptics.
    Beran RG; Rischbieth RH
    Med J Aust; 1979 Dec; 2(11):603-4. PubMed ID: 119151
    [No Abstract]   [Full Text] [Related]  

  • 13. Carnitine in Alleviation of Complications Caused by Acute Valproic Acid Toxicity; an Exprimental Study on Mice.
    Jamshidzadeh A; Heidari R; Shams M; Ebrahimi-Sharghi M; Marashi SM
    Arch Acad Emerg Med; 2024; 12(1):e20. PubMed ID: 38371450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embryonic Hypotaurine Levels Contribute to Strain-Dependent Susceptibility in Mouse Models of Valproate-Induced Neural Tube Defects.
    Steele JW; Lin YL; Chen N; Wlodarczyk BJ; Chen Q; Attarwala N; Venkatesalu M; Cabrera RM; Gross SS; Finnell RH
    Front Cell Dev Biol; 2022; 10():832492. PubMed ID: 35265619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of PLA2G4A attenuated valproic acid- induced lysosomal membrane permeabilization and restored impaired autophagic flux: Implications for hepatotoxicity.
    Wang ML; Zhang YJ; He DL; Li T; Zhao MM; Zhao LM
    Biochem Pharmacol; 2024 Jul; 227():116438. PubMed ID: 39025409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue strategies for valproic acid overdose poisoning: Case series and literature review.
    Liu R; Xiao L; Hu Y; Yan Q; Liu X
    Clin Case Rep; 2024 Jan; 12(1):e8367. PubMed ID: 38161627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of valproic acid steady-state serum levels in adult and pediatric psychiatric inpatients: a comparative analysis.
    Avrahami M; Liwinski T; Eckstein Z; Peskin M; Perlman P; Sarlon J; Lang UE; Amital D; Weizman A
    Psychopharmacology (Berl); 2024 May; ():. PubMed ID: 38733528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of an automatic machine learning model to predict abnormal increase of transaminase in valproic acid-treated epilepsy.
    Ma H; Huang S; Li F; Pang Z; Luo J; Sun D; Liu J; Chen Z; Qu J; Qu Q
    Arch Toxicol; 2024 Jun; ():. PubMed ID: 38879852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-treatment risk predictors of valproic acid-induced dyslipidemia in pediatric patients with epilepsy.
    Liang T; Lin C; Ning H; Qin F; Zhang B; Zhao Y; Cao T; Jiao S; Chen H; He Y; Cai H
    Front Pharmacol; 2024; 15():1349043. PubMed ID: 38628642
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.